Track topics on Twitter Track topics that are important to you
Italfarmaco has its eyes set on bringing a new treatment that targets the underlying mechanism of the blood disorder Polycythemia Vera.
Italfarmaco Group, a specialty pharmaceutical company, today announced both an oral and a poster presentation at the 59th American Society of Hematology (ASH) Meeting & Exposi...
Italfarmaco Group, a specialty pharmaceutical company, today announced the positive results from two clinical trials evaluating its proprietary histone deacetylase (HDAC) inhibito...
SummaryItalfarmaco SpA Italfarmaco, a subsidiary of Italfarmaco Holding SpA, is a pharmaceutical and chemical company which develops, manufactures, commercializes, and licences pharmaceutical drugs. T...
Study Objectives: To determine whether, in patients with large acute myocardial infarction undergoing primary or rescue angioplasty, the administration of subcutaneous Lenograstim [recombi...
Italfarmaco is a specialty pharmaceutical company engaged in the discovery, development, manufacturing and marketing of branded prescription and nonprescription products in more t...
We have published hundreds of Italfarmaco news stories on BioPortfolio along with dozens of Italfarmaco Clinical Trials and PubMed Articles about Italfarmaco for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Italfarmaco Companies in our database. You can also find out about relevant Italfarmaco Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...